Omacetaxine Mepesuccinate
Back to searchMolecule Structure
Scientific Name
Omacetaxine Mepesuccinate
Description of the Drug
Omacetaxine mepesuccinate is a cephalotaxine used in the treatment of Chronic Myeloid Leukemia (CML) that is intolerant to or resistant to two or more tyrosine kinase inhibitors.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04865
http://www.drugbank.ca/drugs/DB04865
Brand Name(s)
Synribo
Company Owner(s)
Teva Pharmaceuticals International Gmbh
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL12745687 | |
| DrugBank | DB04865 | |
| PubChem: Thomson Pharma | 14788079 | 14837137 |
| PubChem | 285033 | |
| NMRShiftDB | 80004772 | |
| LINCS | LSM-3716 | |
| Nikkaji | J123.154E | |
| PDBe | HMT | |
| BindingDB | 50480293 | |
| DrugCentral | 4677 | |
| Metabolights | MTBLC71019 | |
| Guide to Pharmacology | 7454 | |
| rxnorm | SYNRIBO | OMACETAXINE MEPESUCCINATE |
| PubChem: Drugs of the Future | 12013050 | |
| ChEBI | 71019 | |
| ZINC | ZINC000026011099 |
